Collegium Pharmaceutical (COLL) Net Margin (2016 - 2026)
Collegium Pharmaceutical's (COLL) quarterly Net Margin came in at 7.49% in Q1 2026, up 613.0% year-on-year from 1.05% in Q1 2025, and down 9.28% quarter-over-quarter from 8.26% in Q4 2025.
Collegium Pharmaceutical (COLL) Net Margin (2016 - 2026) Analysis & Trends
Collegium Pharmaceutical's Net Margin history runs 11 years deep, the most recent figure standing at 7.49% for Q1 2026.
- On a quarterly basis, Net Margin rose 613.0% year-over-year to 7.49% in Q1 2026; TTM through Mar 2026 was 9.41%, a 96.0% increase from a year earlier, with the FY2025 full-year figure at 8.05%, down 290.0% from the prior year.
- Net Margin eased to 7.49% in Q1 2026 per COLL's latest filing, from 8.26% in the prior quarter.
- Across five years, Net Margin topped out at 33.66% in Q4 2024 and bottomed at 15.6% in Q1 2022.
- The 5-year median for Net Margin is 7.49% (2026), against an average of 7.06%.
- Biggest YoY gain for Net Margin was 6020 bps in 2022; the steepest drop was 9343 bps in 2022.
- Year by year, Net Margin stood at 5.12% in 2022, then soared by 517 bps to 21.33% in 2023, then jumped by 58 bps to 33.66% in 2024, then slumped by 75 bps to 8.26% in 2025, then slipped by 9 bps to 7.49% in 2026.
- Per Business Quant, the three latest COLL Net Margin figures stand at 7.49% (Q1 2026), 8.26% (Q4 2025), and 15.05% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 9.29% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 26.57% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -33.66% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 35.18% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 5.03% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 24.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 4.16% |
| 10 | Collegium Pharmaceutical | 1.14 Bn | 853.50 Mn | 117.25 Mn | 7.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.49% |
| Dec 31, 2025 | 8.26% |
| Sep 30, 2025 | 15.05% |
| Jun 30, 2025 | 6.37% |
| Mar 31, 2025 | 1.36% |
| Dec 31, 2024 | 33.66% |
| Sep 30, 2024 | 5.86% |
| Jun 30, 2024 | 13.50% |
| Mar 31, 2024 | 19.12% |
| Dec 31, 2023 | 21.33% |
| Sep 30, 2023 | 15.09% |
| Jun 30, 2023 | 9.60% |
| Mar 31, 2023 | -12.04% |
| Dec 31, 2022 | -5.12% |
| Sep 30, 2022 | 0.36% |
| Jun 30, 2022 | -4.20% |
| Mar 31, 2022 | -15.60% |
| Dec 31, 2021 | -65.31% |
| Sep 30, 2021 | 10.21% |
| Jun 30, 2021 | 89.23% |